204 related articles for article (PubMed ID: 35836536)
1. Systematic review and meta-analysis of the efficacy and safety of high-intensity focused ultrasound combined with transarterial chemoembolization and transarterial chemoembolization alone in the treatment of liver cancer.
Hu J; Mao H; He Y
Transl Cancer Res; 2022 Jun; 11(6):1678-1688. PubMed ID: 35836536
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
Li L; Tian J; Liu P; Wang X; Zhu Z
Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
[TBL] [Abstract][Full Text] [Related]
3. High-intensity focused ultrasound versus transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis.
Wang YB; Zeng HS; Salameen H; Miao CM; Chen L; Ding X
Int J Radiat Biol; 2023; 99(12):1879-1889. PubMed ID: 37523652
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and meta-analysis on the efficacy and safety of transcatheter arterial chemoembolization combined with radiofrequency ablation in the treatment of primary liver cancer.
Yu Y; Fu J; Xia P; Chu C
Transl Cancer Res; 2022 May; 11(5):1297-1308. PubMed ID: 35706808
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: a meta-analysis.
Liao M; Huang J; Zhang T; Wu H
PLoS One; 2013; 8(7):e68453. PubMed ID: 23844203
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter Arterial Chemoembolization in Combination With High-Intensity Focused Ultrasound for Intermediate and Advanced Hepatocellular Carcinoma: A Meta-Analysis.
Wang YB; Ma R; Wang ZB; Shi QL; Zhang L; Chen WZ; Gong JP; Bai J
Front Oncol; 2022; 12():797349. PubMed ID: 35419281
[TBL] [Abstract][Full Text] [Related]
7. The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis.
Ma X; Li RS; Wang J; Huang YQ; Li PY; Wang J; Su HB; Wang RL; Zhang YM; Liu HH; Zhang CE; Ma ZJ; Wang JB; Zhao YL; Xiao XH
Front Pharmacol; 2016; 7():70. PubMed ID: 27065861
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis on radiofrequency ablation in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Cao JH; Zhou J; Zhang XL; Ding X; Long QY
J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):692-700. PubMed ID: 25318879
[TBL] [Abstract][Full Text] [Related]
9. [Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].
Li XQ; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1341-62. PubMed ID: 23257126
[TBL] [Abstract][Full Text] [Related]
10. Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Fu Y; Zhao X; Yun Q; Zhu X; Zhu Y; Li Q; Hu K; Wang J; Qiao Z
Int J Clin Exp Med; 2015; 8(7):10388-400. PubMed ID: 26379829
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy--preliminary observations.
Kim J; Chung DJ; Jung SE; Cho SH; Hahn ST; Lee JM
Br J Radiol; 2012 Oct; 85(1018):e940-6. PubMed ID: 22553305
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
Ni JY; Liu SS; Xu LF; Sun HL; Chen YT
World J Gastroenterol; 2013 Jun; 19(24):3872-82. PubMed ID: 23840128
[TBL] [Abstract][Full Text] [Related]
13. High-intensity focused ultrasound alone or combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with unsuitable indications for hepatectomy and radiofrequency ablation: a phase II clinical trial.
Gu L; Shen Z; Ji L; Ng DM; Du N; He N; Fan X; Yan K; Zheng Z; Chen B; Ma L; Qiu G; Chen P; Zheng J; Yang T
Surg Endosc; 2022 Mar; 36(3):1857-1867. PubMed ID: 33788029
[TBL] [Abstract][Full Text] [Related]
14. [Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma].
Wu Y; Li J; Zhang SJ; Zhao YF; Zhao LS; Ma XX; Feng LS; Fan ZJ
Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):691-4. PubMed ID: 23157899
[TBL] [Abstract][Full Text] [Related]
15. A comparison of transcatheter arterial chemoembolization used with and without apatinib for intermediate- to advanced-stage hepatocellular carcinoma: a systematic review and meta-analysis.
Zhao S; Zhang T; Dou W; Wang E; Wang M; Wang C; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):542. PubMed ID: 32411765
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma: A systematic review and meta-analysis.
Song P; Hai Y; Ma W; Zhao L; Wang X; Xie Q; Li Y; Wu Z; Li Y; Li H
Medicine (Baltimore); 2018 May; 97(18):e0613. PubMed ID: 29718867
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis.
Liao M; Zhu Z; Wang H; Huang J
Scand J Gastroenterol; 2017; 52(6-7):624-634. PubMed ID: 28276833
[TBL] [Abstract][Full Text] [Related]
18. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis.
Jiang C; Cheng G; Liao M; Huang J
World J Surg Oncol; 2021 Mar; 19(1):81. PubMed ID: 33741001
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.
Cheung TT; Poon RT; Jenkins CR; Chu FS; Chok KS; Chan AC; Tsang SH; Dai WC; Yau TC; Chan SC; Fan ST; Lo CM
Liver Int; 2014 Jul; 34(6):e136-43. PubMed ID: 24451026
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of Apatinib combined with TACE in the treatment of hepatocellular carcinoma: a meta-analysis.
Gong A; Li X
World J Surg Oncol; 2022 Mar; 20(1):69. PubMed ID: 35246145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
